Work

Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization

Year: 2022

Type: editorial

Source: British Journal of Clinical Pharmacology

DOI: 10.1111/bcp.15548

Authors: Robert Likic, James W. Dear, Lionel D. Lewis

Institutions: University Hospital Centre Zagreb, University of Zagreb, The Queen's Medical Research Institute, University of Edinburgh, Dartmouth–Hitchcock Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W4303473128

Cites: 13

Cited by:

Related to: 10